Enter your login e-mail to the account
Search
- CHRONIC LYMPHOCYTIC LEUKEMIA
prof. MUDr. Elena Tóthová, CSc.
(12/2008, Topic )
- Tumors of the central nervous system in children
MUDr. Zdeněk Pavelka, MUDr. Karel Zitterbart
(1/2011, From the boundary of neurology ) - Current strategy for treatment of high-grade gliomas
prof. MUDr. Pavel Šlampa, CSc., doc. MUDr. Radim Jančálek, Ph.D., MUDr. Tomáš Kazda, MUDr. Petr Pospíšil
(5/2016, Main topic )
- Klinická skúsenosť s liečbou mnohopočetného myelómu monoklonálnou protilátkou v monoterapii – kazuistika
MUDr. Natália Štecová
(4/2018, Original articles ) - News in the treatment of lung cancer
doc. MUDr. Peter Beržinec, CSc.
(4/2012, Review articles ) - Publikujeme v zahraničí
(6/2014, Information & comments ) - Monoclonal antibodies in the treatment of chronic lymphocytic leukemia
MUDr. Eva Mikušková, MUDr. Ľudmila Demitrovičová, MUDr. Juraj Chudej, PhD.
(6/2014, Oncohematology Review ) - Publikujeme v zahraničí
doc. MUDr. Michal Mego, PhD.
(4/2012, Information & comments ) - Treatment of multiple myeloma
MUDr. Emília Flochová, PhD., MUDr. Lucia Stančiaková
(5/2016, Spectrum ) - Current treatment options of transplant-ineligible patients with multiple myeloma
prof. MUDr. Elena Tóthová, CSc., MUDr. Adriana Kafková, PhD.
(3/2013, Focus ) - Publikujeme v zahraničí
(1/2011, Information & comments ) - HIGH-DOSE THERAPY IN MALIGNANT LYMPHOMAS
MUDr. Andrej Vranovský
(2/2008, Review articles ) - THE TREATMENT EFFECT EVALUATION OF MALIGNANT LYMPHOMAS
MUDr. Jan Hudeček, CSc., MUDr. Ivana Plameňová, MUDr. Juraj Chudej
(2/2008, Review articles ) - Position FOLFOX chemotherapy in the outpatient treatment of colorectal cancer
MUDr. Marián Kakalejčík, MUDr. Ján Vongrey, MUDr. Andrej Orolín
(3/2014, Review articles ) - Publikujeme v zahraničí
(3/2014, Information & comments ) - Gastrointestinal stromal tumors and some new treatment options
MUDr. Iveta Andrezálová Vochyanová
(3/2015, Review articles ) - How to improve the first line treatment of NSCLC with EGFR mutation?
doc. MUDr. Peter Beržinec, CSc.
(6/2016, Review articles ) - Bevacizumab in the treatment of patients with ovarian carcinoma
MUDr. Michaela Kubíčková, MUDr. Jozef Šufliarsky, PhD., MUDr. Štefánia Lišková, MUDr. Tomáš Minárik, PhD., MUDr. Andrej Jurík, MUDr. Tibor Lengyel, PhD., MUDr. Igor Slezák, PhD.
(6/2015, Original articles & case reports ) - Gastrointestinal stromal tumors (GISTs)
MUDr. Iveta Andrezálová Vochyanová
(3/2011, Review articles ) - Publikujeme v zahraničí
(6/2015, Information & comments ) - Clinical significance of PD-L1 immune check-point measurement
MUDr. Peter Kasan
(2/2017, Drugs & drug classes ) - The application of biological treatment in metastatic colorectal carcinoma in relation to primary tumor localization
MUDr. Miriam Drahokoupilová, MUDr. Mária Novisedláková, MUDr. Vladimír Václav
(5/2017, Original articles & case reports ) - Topotecan in the treatment of recurrent ovarian carcinoma – the retrospective analysis
doc. MUDr. Jozef Mardiak, CSc., MUDr. Jozef Šufliarsky, MUDr. Oliver Sadovský, CSc., MUDr. Tomáš Minarik, MUDr. Michaela Kubíčková, MUDr. Tibor Lengyel, MUDr. Bohuslav Nižňanský
(6/2009, Original articles & case reports ) - Diagnostic and prognostic factors in multiple myeloma
MUDr. Zdenka Štefániková
(3/2016, Spectrum ) - Neuroendocrine tumors from oncologist's point of view
doc. MUDr. Mária Wagnerová, CSc.
(4/2011, Review articles ) - Systemic treatment of bladder cancer – neoadjuvant, adjuvant and palliative chemotherapy
MUDr. Branislav Bystrický, MUDr. Filip Kohútek, MUDr. Peter Kohútek, MUDr. Tomáš Sedláček
(3/2016, Review articles ) - Treatment of advanced metastatic lung cancer in older patients
doc. MUDr. Peter Beržinec, CSc.
(5/2012, Main topic ) - Publikujeme v zahraničí
(3/2016, Information & comments ) - Data back Merck’s Keytruda for first-line NSCLC
doc. MUDr. Peter Beržinec, CSc.
(3/2016, Information & comments ) - Castration resistant prostate cancer – something new in the year 2014?
doc. MUDr. Jozef Marenčák, PhD.
(4/2014, Main topic ) - First line treatment of metastatic renal cell cancer in 2014
MUDr. Mária Rečková
(4/2014, Main topic ) - Ewing sarcoma – our treatment experiences
MUDr. Vanda Mikudová, MUDr. Andrej Jurík, MUDr. Michaela Kubíčková, MUDr. Tomáš Minárik, PhD., MUDr. Silvia Cingelová, PhD., MUDr. Jozef Šufliarsky, PhD., MUDr. Michaela Sojáková, PhD.
(1/2019, Main topic ) - Treatment of relapsed and refractory myeloma
MUDr. Alexander Wild
(4/2013, Focus ) - Aktuálne problémy v manažmente gastrointestinálnych malignít, Bojnice 2006
MUDr. Tomáš Šálek
(4/2006, Events ) - Nové perspektívy v liečbe pokročilého a metastatického HR+ HER2- karcinómu prsníka
MUDr. Miroslava Malejčíková, MUDr. Silvia Jurišová
(2/2018, Review articles ) - Kritériá minimálnej reziduálnej choroby pri chronickej lymfocytovej leukémii
MUDr. Juliana Holasová, MUDr. Alexander Wild, RNDr. Soňa Ölvecká, Mgr. Mariana Jacková
(2/2018, Review articles ) - Dual inhibition after failure of NSAI as a solution to hormone therapy resistance
MUDr. Bibiána Vertáková Krakovská, PhD.
(1/2015, Review articles ) - Eribulin in treatment of breast cancer
doc. MUDr. Mária Wagnerová, CSc., MUDr. Hana Garanová
(1/2015, Drugs & drug classes ) - Zriedkavý nádor hrudníka: malígny pleurálny mezotelióm
MUDr. Lucia Denková, MUDr. František Sándor, PhD., FCCP
(3/2018, Main topic ) - The role of PARP inhibitors in the treatment of breast cancer
MUDr. Eliška Volochová, MUDr. Marián Streško, PhD.
(2/2022, Main topic ) - Publikujeme v zahraničí
(1/2015, Information & comments ) - FLT3mutácie u pacienta s AML: incidencia, možnosti diagnostiky a vplyv na manažment liečby
MUDr. Eva Mikušková, PhD., RNDr. Renata Lukačková, RNDr. Imrich Hikkel, PhD., Mgr. Michaela Zrubcová
(3/2018, Original articles & case reports ) - Daratumumab v kombinovanej liečbe mnohopočetného myelómu
MUDr. Ľubica Harvanová, PhD., doc. MUDr. Martin Mistrík, PhD., prof. MUDr. Angelika Bátorová, PhD.
(3/2018, Drugs & drug classes ) - Publikujeme v zahraničí
redakcia
(3/2018, Information & comments ) - Relapsed/refractory diffuse large B-cell lymphoma
MUDr. Miriam Ladická
(4/2015, Spectrum ) - Systemic treatment of advanced, persistent or recurrent cervical cancer
MUDr. Mária Rečková
(4/2015, Review articles ) - THE INTRODUCTION TO INTERPRETATION OF CLINICAL TRIALS – Part II.
MUDr. Michal Mego, PhD., MUDr. Mária Rečková
(3/2008, Review articles ) - Immunotherapy for lung cancer
doc. MUDr. Peter Beržinec, CSc.
(4/2016, Main topic ) - The efect of CDK 4/6 inhibition on overal survival in metastatic breast cancer
MUDr. Bibiána Vertáková Krakovská, PhD.
(2/2020, Review articles ) - Treatment alternatives in newly diagnosed patients with chronic myeloid leukemia
MUDr. Zuzana Sninská, PhD.
(3/2012, Topic of the year ) - Current possibilities of immunotherapy in the treatment of malignant melanoma
MUDr. Iveta Andrezálová Vochyanová
(4/2016, Main topic ) - Contemporary trends in prostate brachytherapy
MUDr. Pavol Lukačko, Mgr. Jozef Grežďo, PhD., MUDr. Branislav Obšitník, PhD.
(4/2016, Review articles ) - GASTROINTESTINAL STROMAL TUMOR – A COMPREHENSIVE VIEW OF DIAGNOSTICS AND TREATMENT
MUDr. Andrea Cipková, MPH.
(6/2008, Review articles ) - New possibilities and view for treatment of castration resistent prostate cancer
doc. MUDr. Igor Andrašina, CSc., MUDr. Radovan Barilla, PhD.
(1/2012, Review articles ) - Lorlatinib in 1st line ALK-positive non-small cell lung cancer
MUDr. Lucia Denková
(4/2024, Drugs & drug classes ) - Therapy for chronic myeloid leukemia: Past, present and future
prof. MUDr. Elena Tóthová, CSc.
(1/2012, Topic of the year ) - Integrating bevacizumab in the first line treatment of ovarian cancer – the retrospective analysis
doc. MUDr. Mária Wagnerová, CSc., MUDr. Hana Garanová, RNDr. Jana Koperdáková, PhD.
(5/2015, Original articles & case reports ) - Mantle cell lymphoma
MUDr. Radoslav Greksák, PhD.
(1/2024, Main topic ) - Publikujeme v zahraničí
(1/2016, Information & comments ) - Treatment of chronic lymphocytic leukemia with second-generation Bruton›s tyrosine kinase inhibitors – retrospective analysis and clinical experience
MUDr. Firas Farkaš, PhD., MUDr. Zdenka Štefániková, prof. MUDr. Angelika Bátorová, PhD.
(6/2025, Original articles ) - Treatment of gastrointestinal stromal tumours
MUDr. Zdeněk Linke, MUDr. Jana Prausová
(4/2010, Review articles ) - Novinky z American Society of Clinical Oncology 2010
doc. MUDr. Peter Beržinec, CSc., MUDr. Tomáš Šálek, prof. MUDr. Stanislav Špánik, CSc., MUDr. Mária Rečková
(4/2010, Events ) - Publikujeme v zahraničí
doc. MUDr. Michal Mego, PhD.
(6/2012, Information & comments ) - Publikujeme v zahraničí
(1/2017, Information & comments ) - A new era in the treatment of chronic lymphocytic leukemia: venetoclax as a tool for modern therapy – a retrospective group from Slovakia
MUDr. Firas Farkaš, PhD., Prof. MUDr. Mikuláš Hrubiško, CSc., MUDr. Zdenka Štefániková, MUDr. Zuzana Sninská, PhD., MUDr. Eva Luptáková, MUDr. Jana Juranová, MUDr. Ladislav Fekete, MUDr. Enikő Radi, MUDr. Eva Dingová, prof. MUDr. Angelika Bátorová, PhD.
(3/2025, Original articles ) - Initial treatment of chronic lymphocytic leukaemia
MUDr. Emília Flochová, PhD.
(5/2014, Oncohematology Review ) - Treatment of relapse and refractory chronic lymphocytic leukemia
MUDr. Natália Štecová
(5/2014, Oncohematology Review ) - RESECTION OF HEPATAL METASTASES IN PATIENTS WITH COLORECTAL CARCINOMA – MULTIDISCIPLINARY APPROACH
MUDr. Zuzana Hlavatá
(6/2007, Review articles ) - New possibilities in the 3rd and 4th line of treatment of metastatic colorectal cancer
MUDr. Tomáš Šálek
(4/2017, Drugs & drug classes )












